Integrating Precision Oncology in Prostate Cancer: Current Role of PARP Inhibitors and Combinations

Faculty: Tian Zhang, MD, MHS
Disclosures

Faculty

Tian Zhang, MD, MHS
Associate Professor
Director of Clinical Research
Division of Hematology and Oncology, Dept of Internal Medicine
Associate Director for Clinical Research
Simmons Comprehensive Cancer Center
UT Southwestern Medical Center

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading